What’s on Teva’s mind?

Shares of the mid-tier pharmaceutical firms has been in steep rally, since a health ministry official said that generic drug giant Teva enters into an agreement with a Korean firm over possible merger.

So far, several Korean firms, such as Myungmoon Pharm, Yuyu Pharm, Kukje Pharm and Korea United, have been cited as possible target of merger by Teva, but they dismissed the rumor in their reg...